MedPath
TGA Approval

NMN 18000mg + Resveratrol (413527)

413527

NMN 18000mg + Resveratrol

Auspro Health Pty Ltd

July 14, 2023

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

nicotinamide mononucleotide

Reynoutria japonica

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NMN 18000mg + Resveratrol (413527) - TGA 批准文号 | MedPath